|
|
|
|
|
|
|
|
Full text
The Sister Study (NCT00047970) is a prospective cohort of 50,884 women aged 35–74 years who had a sister with breast cancer but who did not have breast cancer themselves [18], [19].
Background
Nonsteroidal anti-inflammatory drugs (NSAIDs) have been shown to inhibit several pathways
in experimental models of breast carcinogenesis, but epidemiological evidence remains
insufficient to support their use for breast cancer prevention. We examined the association
between use of NSAIDs and breast cancer risk in a prospective cohort.
Methods
The Sister Study is a prospective cohort study of women who had a sister(s) with breast
cancer. As of December 2013, 2118 incident breast cancers were ascertained from 50,884
women enrolled between 2003 and 2009. Lifetime history of NSAID use was estimated
from self-reported data in pill-years, with 1 pill per week for a year equivalent
to 1 pill-year. Cox regression models were used to estimate hazard ratios (HRs) of
breast cancer in relation to pill-years of use for different NSAIDs, with adjustment
for potential confounders.....
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.